Total Payments
$2,393
2024 Payments
$283.43
Companies
18
Transactions
132
Medicare Patients
5,941
Medicare Billing
$444,000
Payment Breakdown by Category
Food & Beverage$2,318 (96.9%)
Education$75.30 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,318 | 130 | 96.9% |
| Education | $75.30 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $476.45 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.69 | 19 | $0 (2023) |
| Allergan, Inc. | $330.06 | 22 | $0 (2022) |
| ABBVIE INC. | $215.74 | 12 | $0 (2024) |
| Shire North American Group Inc | $200.50 | 11 | $0 (2018) |
| Alcon Vision LLC | $149.98 | 9 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $133.50 | 8 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $76.08 | 4 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $74.54 | 4 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $74.32 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.43 | 15 | ABBVIE INC. ($79.56) |
| 2023 | $438.39 | 16 | Novartis Pharmaceuticals Corporation ($207.46) |
| 2022 | $355.93 | 21 | ABBVIE INC. ($104.25) |
| 2021 | $411.15 | 26 | Allergan, Inc. ($114.97) |
| 2020 | $314.62 | 18 | Sun Pharmaceutical Industries Inc. ($121.45) |
| 2019 | $223.62 | 15 | Sun Pharmaceutical Industries Inc. ($71.77) |
| 2018 | $141.72 | 10 | Shire North American Group Inc ($50.89) |
| 2017 | $224.15 | 11 | Shire North American Group Inc ($149.61) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: EYE CARE | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: EYE CARE | ||||||
| 10/01/2024 | Alcon Vision LLC | Precision 7 (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/15/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Ophthalmology | ||||||
| 04/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: EYE CARE | ||||||
| 04/02/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/08/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Ophthalmology | ||||||
| 02/08/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Ophthalmology | ||||||
| 01/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 01/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: EYE CARE | ||||||
| 12/17/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Ophthalmology | ||||||
| 11/07/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Ophthalmology | ||||||
| 10/02/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Ophthalmology | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $66.02 | General |
| Category: Ophthalmology | ||||||
| 09/12/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Ophthalmology | ||||||
| 08/22/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $49.72 | General |
| Category: Ophthalmology | ||||||
| 08/14/2023 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $22.69 | General |
| 06/27/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Ophthalmology | ||||||
| 06/06/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $55.54 | General |
| Category: Ophthalmology | ||||||
| 05/15/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,714 | 9,443 | $351,120 | $131,974 |
| 2022 | 10 | 1,246 | 9,063 | $256,185 | $93,256 |
| 2021 | 10 | 1,406 | 8,618 | $323,220 | $104,865 |
| 2020 | 11 | 1,575 | 11,398 | $456,015 | $113,906 |
Total Patients
5,941
Total Services
38,522
Medicare Billing
$444,000
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92250 | Photography of the retina | Office | 2021 | 241 | 258 | $19,350 | $6,566 | 33.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 56 | 56 | $12,480 | $4,243 | 34.0% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 11 | 12 | $6,500 | $2,818 | 43.3% |
| 76519 | Ultrasound of eye for determination of lens power | Office | 2021 | 50 | 100 | $5,500 | $2,390 | 43.5% |
| 92082 | Measurement of field of vision during daylight conditions, intermediate examination | Office | 2021 | 62 | 86 | $4,795 | $1,890 | 39.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 73 | 73 | $4,745 | $1,769 | 37.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 13 | 13 | $910.00 | $338.30 | 37.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 674 | 801 | $144,180 | $60,664 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 193 | 298 | $32,780 | $13,687 | 41.8% |
| 92250 | Photography of the retina | Office | 2020 | 285 | 292 | $29,415 | $8,547 | 29.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 92 | 92 | $19,975 | $8,085 | 40.5% |
| 66984 | Removal of cataract with insertion of lens | Office | 2020 | 52 | 7,910 | $153,670 | $7,313 | 4.8% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2020 | 21 | 21 | $11,000 | $5,200 | 47.3% |
| 76519 | Ultrasound of eye for determination of lens power | Office | 2020 | 68 | 181 | $11,642 | $3,842 | 33.0% |
| 66982 | Complex removal of cataract with insertion of lens | Office | 2020 | 13 | 1,620 | $37,800 | $2,079 | 5.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 95 | 95 | $7,945 | $2,032 | 25.6% |
| 92082 | Measurement of field of vision during daylight conditions | Office | 2020 | 61 | 66 | $5,593 | $1,806 | 32.3% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 21 | 22 | $2,015 | $651.70 | 32.3% |
About Dr. C Mcquaig, MD
Dr. C Mcquaig, MD is a Ophthalmology healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215999818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Mcquaig, MD has received a total of $2,393 in payments from pharmaceutical and medical device companies, with $283.43 received in 2024. These payments were reported across 132 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,318).
As a Medicare-enrolled provider, Mcquaig has provided services to 5,941 Medicare beneficiaries, totaling 38,522 services with total Medicare billing of $444,000. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Milledgeville, GA
- Active Since 04/06/2006
- Last Updated 03/09/2011
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1215999818
Products in Payments
- XIIDRA (Drug) $658.49
- LUMIGAN (Drug) $344.20
- Cequa (Drug) $283.23
- VUITY (Drug) $134.98
- INVELTYS (Drug) $133.50
- XELPROS (Drug) $101.77
- BROMSITE (Drug) $91.45
- PROLENSA (Drug) $79.86
- Rocklatan (Drug) $69.41
- VYZULTA (Drug) $55.34
- XDEMVY (Drug) $52.87
- TRAVATAN Z (Drug) $34.54
- RESTASIS (Drug) $34.24
- BESIVANCE (Drug) $31.82
- rhopressa (Drug) $29.58
- PROKERA (Device) $28.56
- TYRVAYA (Drug) $27.08
- OXERVATE (Drug) $24.68
- Precision 7 (Device) $22.32
- MIEBO (Drug) $22.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.